Navigation Links
Mithridion wins grants for Alzheimer's research

Madison, Wis. - Mithridion, Inc., a biopharmaceutical startup that is developing drugs to disrupt the progress of Alzheimer's disease, has secured $296,800 in federal grants to evaluate tests for drug candidates.

The twin grants, awarded by the National Institute on Aging, a branch of th......

Full article >>> the brain that might shield neurons from Amyloid beta, the primary toxin in Alzheimers.

"The advantage of small molecules is that they can be synthesized by chemical means, they can be accurately analyzed, they are relatively low cost for production, and they have a very well-trodden path for getting Food and Drug Administration approval," Twose sa......

Full article >>> > "That's a major advantage and it really stimulates innovation," Twose said. "These grants are really the lifeblood of many, many biotech companies."

......

Full article >>>
'"/>

Source:wistechnology.com By Chris Fleissner 08/29/06


Related biology technology :

1. Mithridion raises $1.6M through angel networks
2. Digital Healthcare Conference, Mithridion, lack of degrees
3. Madison-based Mithridion seeks to capitalize on Alzheimers breakthrough
4. State to offer $850K in high-tech training grants
5. Venture-backed firms could become eligible for federal SBIR grants
6. NASDAQ grants Merge more time for compliance
7. Morgridge seed grants attract over 220 proposals
8. Medical College researchers win federal grants
9. NSF grants bolster integrative graduate study at UW-Madison
10. Three state businesses receive technology grants
11. Visonex plans to expand with state grants, loan
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... Jan. 18, 2017 BD (Becton, Dickinson and Company) (NYSE: ... that it will host a live webcast of its Annual Meeting ... The webcast can be accessed from the BD ... through Tuesday, January 31, 2017. ... About BD BD is a global medical ...
(Date:1/18/2017)... Mass. , Jan. 18, 2017   Boston ... novel compounds designed to target cancer stemness pathways, will ... investigational compound, napabucasin, at the 2017 ASCO Gastrointestinal Cancers ... Francisco . Napabucasin is an ... by targeting STAT3. i Cancer stem cells (CSCs) ...
(Date:1/18/2017)... ... January 18, 2017 , ... Executive search firm Slone ... continued commitment to the advancement of the clinical trials segment. Hosted in Miami, ... clinical trial planning and management. , As executive talent specialists in the ...
(Date:1/18/2017)... Frederick, Maryland (PRWEB) , ... January 18, 2017 ... ... of two new federally funded bio-focused Manufacturing Innovation Institutes (MII). U.S. Secretary of ... Innovation in Manufacturing Biopharmaceuticals (NIIMBL), and the Department of Defense has announced the ...
Breaking Biology Technology:
(Date:12/22/2016)... -- SuperCom (NASDAQ:   SPCB ... Public Safety, HealthCare, and Finance sectors announced today that Leaders in ... implement and deploy a community-based supportive services program to reduce recidivism ... further expanding its presence in the state. ... This new program, which is expected to ...
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
(Date:12/16/2016)... 2016 The global wearable medical device market, in terms ... from USD 5.31 billion in 2016, at a CAGR of 18.0% ... ... advancements in medical devices, launch of a growing number of smartphone-based ... among healthcare providers, and increasing focus on physical fitness. ...
Breaking Biology News(10 mins):